2238 Rakocevic, Goran - Jefferson Medical College - Thomas Jefferson University
Goran Rakocevic, MD

Goran Rakocevic, MD

Contact Dr. Rakocevic

900 Walnut Street
Suite 200
Philadelphia, PA 19107

(215) 955-7952
(215) 955-9976 fax

Most Recent Peer-reviewed Publications

  1. Pearls and oy-sters: Neurosyphilis presenting as mesial temporal encephalitis
  2. Reply
  3. HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue
  4. Autoimmune stiff person syndrome and related myelopathies: Understanding of electrophysiological and immunological processes
  5. Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity
  6. Atypical clinically diagnosed stiff-person syndrome response to dantrolene-a refractory case
  7. Reply: Comment on alemtuzumab and inclusion body myositis
  8. Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis
  9. Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy
  10. T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis
  11. Inclusion body myositis with human immunodeficiency virus infection: Four cases with clonal expansion of viral-specific T cells
  12. Intravenous immune globulin in hereditary inclusion body myopathy: A pilot study
  13. Autoimmunity to GABA A-receptor-associated protein in stiff-person syndrome
  14. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies
  15. A neuropsychological assessment of phobias in patients with stiff person syndrome
  16. Bilateral pallidotomy for severe dystonia in an 18-month-old child with glutaric aciduria
  17. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: Correlation with clinical severity
  18. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: Significance for CD8 + T cell cytotoxicity
  19. Hypoglycosylation of α-dystroglycan in patients with hereditary IBM due to GNE mutations
  20. Myasthenia gravis, thymoma, and intestinal pseudo-obstruction
0